|
1
|
Huang J, Liu K, Song D, Ding M, Wang J,
Jin Q and Ni J: Krüppel-like factor 4 promotes high-mobility group
box 1-induced chemotherapy resistance in osteosarcoma cells. Cancer
Sci. 107:242–249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li YS, Deng ZH, Zeng C and Lei GH: JNK
pathway in osteosarcoma: Pathogenesis and therapeutics. J Recept
Signal Transduct Res. 36:465–470. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chakravarthi PS, Kattimani VS, Prasad LK
and Satish PR: Juxtacortical osteosarcoma of the mandible:
Challenges in diagnosis and management. Natl J Maxillofac Surg.
6:127–131. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou W, Zhu Y, Chen S, Xu R and Wang K:
Fibroblast growth factor receptor 1 promotes MG63 cell
proliferation and is associated with increased expression of
cyclin-dependent kinase 1 in osteosarcoma. Mol Med Rep. 13:713–719.
2016.PubMed/NCBI
|
|
5
|
Yang J, Cheng D, Zhou S, Zhu B, Hu T and
Yang Q: Overexpression of X-Box Binding Protein 1 (XBP1) Correlates
to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human
Osteosarcoma. Int J Mol Sci. 16:28635–28646. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shao Y, Wang C, Hong Z and Chen Y:
Inhibition of p38 mitogen-activated protein kinase signaling
reduces multidrug transporter activity and anti-epileptic drug
resistance in refractory epileptic rats. J Neurochem.
136:1096–1105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J, Liu Q, Fang Z, Hu X, Huang F,
Tang L and Zhou S: Hypoxia induces the proliferation of endothelial
progenitor cells via upregulation of Apelin/APLNR/MAPK signaling.
Mol Med Rep. 13:1801–1806. 2016.PubMed/NCBI
|
|
8
|
Xu W, Yang Z, Zhou SF and Lu N:
Posttranslational regulation of phosphatase and tensin homolog
(PTEN) and its functional impact on cancer behaviors. Drug Des
Devel Ther. 8:1745–1751. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang N, Zhang C, Dill P, Panasyuk G, Pion
D, Koka V, Gallazzini M, Olson EN, Lam H, Henske EP, et al:
Regulation of YAP by mTOR and autophagy reveals a therapeutic
target of tuberous sclerosis complex. J Exp Med. 211:2249–2263.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu J, Lu WY and Cui LL: Clinical
significance of STAT3 and MARK Phosphorylation, and the protein
expression of cyclin D1 in skin squamous cell carcinoma tissues.
Mol Med Rep. 12:8129–8134. 2015.PubMed/NCBI
|
|
11
|
Talbot JJ, Song X, Wang X, Rinschen MM,
Doerr N, LaRiviere WB, Schermer B, Pei YP, Torres VE and Weimbs T:
The cleaved cytoplasmic tail of polycystin-1 regulates
Src-dependent STAT3 activation. J Am Soc Nephrol. 25:1737–1748.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang YH, Li B, Shen L, Shen Y and Chen
XD: The role and clinical significance of YES-associated protein 1
in human osteosarcoma. Int J Immunopathol Pharmacol. 26:157–167.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng ZP, Yan Y, Xia J, Zhang S, Wang M,
Chen J and Xu Y: A phenylacetaldehyde-flavonoid adduct,
8-C-(E-phenylethenyl)- norartocarpetin, exhibits intrinsic
apoptosis andMAPK pathways-related anticancer potential on HepG2,
SMMC-7721 and QGY-7703. Food Chem. 197:1085–1092. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cursons J, Angel CE, Hurley DG, Print CG,
Dunbar PR, Jacobs MD and Crampin EJ: Spatially transformed
fluorescence image data for ERK-MAPK and selected proteins within
human epidermis. Gigascience. 4:632015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Beauvais S, Drevelle O, Lauzon MA, Daviau
A and Faucheux N: Modulation of MAPK signalling by immobilized
adhesive peptides: Effect on stem cell response to BMP-9-derived
peptides. Acta Biomater. 31:241–251. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dreyer JH, Hauck F, Barros MH and
Niedobitek G: pRb and CyclinD1 Complement p16 as
Immunohistochemical Surrogate Markers of HPV Infection in Head and
Neck Cancer. Appl Immunohistochem Mol Morphol. 2015.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu J, Lv S, An J and Lu C: Pre-miR-149
rs71428439 polymorphism is associated with increased cancer risk
and AKT1/cyclinD1 signaling in hepatocellular carcinoma. Int J Clin
Exp Med. 8:13628–13633. 2015.PubMed/NCBI
|
|
18
|
Yang Y, Zhao LH, Huang B, Wang RY, Yuan
SX, Tao QF, Xu Y, Sun HY, Lin C and Zhou WP: Pioglitazone, a PPARγ
agonist, inhibits growth and invasion of human hepatocellular
carcinoma via blockade of the rage signaling. Mol Carcinog.
54:1584–1595. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi QQ, Zuo GW, Feng ZQ, Zhao LC, Luo L,
You ZM, Li DY, Xia J, Li J and Chen DL: Effect of trichostatin a on
anti HepG2 liver carcinoma cells: Inhibition of HDAC activity and
activation of Wnt/β-catenin signaling. Asian Pac J Cancer Prev.
15:7849–7855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Liu H, Wang X, Zeng Z, Xie LQ, Sun
ZG and Wei MX: Preventive effect of Actinidia valvata Dunn extract
on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastrointestinal
cancer in rats. Asian Pac J Cancer Prev. 15:6363–6377. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gopalakrishnan N, Saravanakumar M,
Madankumar P, Thiyagu M and Devaraj H: Colocalization of β-catenin
with Notch intracellular domain in colon cancer: A possible role of
Notch1 signaling in activation of CyclinD1-mediated cell
proliferation. Mol Cell Biochem. 396:281–293. 2014. View Article : Google Scholar : PubMed/NCBI
|
